Validation of an in-clinic enzyme-linked immunosorbent assay kit for diagnosis of Borrelia burgdorferi infection in horses

Journal of Veterinary Diagnostic Investigation

Volumn 20, Issue 3, 2008, Pages 321-324

  Johnson, Amy L ^a,b   Divers, Thomas J ^a   Chang, Yung Fu ^a  

^a Department of Obstetrics Gynecology   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Borrelia burgdorferi; C6; Enzyme linked immunosorbent assay; Equines; IDEXX SNAP test kit; Lyme disease; Serology

Indexed keywords

BORRELIA BURGDORFERI; CANIS; CANIS FAMILIARIS; DIROFILARIA IMMITIS; EQUIDAE; IXODIDA;

BACTERIUM ANTIBODY;

ANALYTICAL EQUIPMENT; ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; BORRELIA BURGDORFERI; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; HORSE; HORSE DISEASE; LYME DISEASE; REPRODUCIBILITY;

ANIMALS; ANTIBODIES, BACTERIAL; BORRELIA BURGDORFERI; ENZYME-LINKED IMMUNOSORBENT ASSAY; HORSE DISEASES; HORSES; LYME DISEASE; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS;

EID: 54549120398     PISSN: 10406387     EISSN: None     Source Type: Journal    
DOI: 10.1177/104063870802000309     Document Type: Article

References (16)

1. Bacon RM, Biggerstaff BJ, Schriefer ME, et al.: 2003, Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J Infect Dis 187:1187-1199.
2. Burgess EC: 1988, Borrelia burgdorferi infection in Wisconsin horses and cows. Ann N Y Acad Sci 539:235-243.
3. Butler CM, Houwers DJ, Jongejan F, van der Kolk JH: 2005, Borrelia burgdorferi infections with special reference to horses: a review. Vet Q 27:146-156.
4. Chang YF, Ku YW, Chang CF, et al.: 2005, Antibiotic treatment of experimentally Borrelia burgdorferi-infected ponies. Vet Microbiol 107:285-294.
5. Chang YF, Novosol V, McDonough SP, et al.: 2000, Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface protein A (rOspA) in horses. Vaccine 18:540-548.
6. Chang YF, Novosol V, McDonough SP, et al.: 2000, Experimental infection of ponies with Borrelia burgdorferi by exposure to Ixodid ticks. Vet Pathol 37:68-76.
7. Fleming RV, Marques AR, Klempner MS, et al.: 2004, Pre-treatment and post-treatment assessment of the C6 test in patients with persistent symptoms and a history of Lyme borreliosis. Eur J Clin Microbiol Infect Dis 23:615-618.
8. 6 ELISA test kit for determination of infection status of dogs naturally exposed to Borrelia burgdorferi. Vet Ther 3:308-315.
9. 6 ELISA test to evaluate the efficacy of a whole-cell bacterin for the prevention of naturally transmitted canine Borrelia burgdorferi infection. Vet Ther 3:420-424.
10. Levy SA, O'Connor TP, Hanscom JL, Shields P: 2003, Evaluation of a canine C6 ELISA Lyme disease test for the determination of the infection status of cats naturally exposed to Borrelia burgdorferi. Vet Ther 4:172-177.
11. Liang FT, Jacobson RH, Straubinger RK, et al.: 2000, Characterization of a Borrelia burgdorferi VlsE invariable region useful in canine Lyme disease serodiagnosis by enzyme-linked immunosorbent assay. J Clin Microbiol 38:4160-4166.
12. Magnarelli LA, Anderson JF, Shaw E, et al.: 1988, Borreliosis in equids in northeastern United States. Am J Vet Res 49:359-362.
13. 6, the conserved immunodominant region of the VlsE surface protein of Borrelia burgdorferi. Clin Diagn Lab Immunol 11:458-462.
14. 6, a conserved immunodominant region of the VlsE lipoprotein, wanes rapidly after antibiotic treatment of Borrelia burgdorferi infection in experimental animals and in humans. J Infect Dis 184:870-878.
15. Philipp MT, Wormser GP, Marques AR, et al.: 2005, A decline in C6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated Lyme borreliosis. Clin Diagn Lab Immunol 12:1069-1074.
16. Sapadin AN, Fleischmajer R: 2006, Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol 54:258-265.